Lineus Medical® is proud to announce the U.S. Food and Drug Administration (FDA) has cleared its flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, midlines, peripherally inserted central...
Health Canada has issued a licence on Lineus Medical's flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, peripherally inserted central catheters, central venous catheters, midlines, IV ports,..
Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients.
A Valentine's Day toast to the most successful black-owned distillery in the world, hosted by Royal Entertainment Events, provides a cocktail-tasting experience in an ode to Black History Month, whiskey, and love
Lineus Medical announces publication of the randomized controlled trial performed at Colorado State University Veterinary Teaching Hospital in the Journal of the American Veterinary Medical Association.
Lineus Medical continues to expand its patent portfolio with the issuance of two new patents. The first issued patent was a Japanese Utility Patent (JP7095097) for SafeBreak® Vascular, a break-away medical device that helps protect peripheral IV lines.
Lineus Medical announces the publication of a pivotal clinical study performed at Hartford Hospital, part of Hartford HealthCare in Hartford, Connecticut, in the March edition of The Journal of Infusion Nursing.
Lineus Medical signed on its fifth distributor in as many months as it continues to expand its distribution network with the addition of Clinical Technology, a specialty distributor of medical products based out of Brecksville, OH.